Conference on CNS Clinical Trials
CNS is one of the largest and fastest growing therapeutic areas of thepharmaceutical market. The ageing of the baby-boom generation combined
with new and emerging treatments for neurodegenerative disorders, including multiple sclerosis, Alzheimer’s disease and Parkinson’s disease, will lead to further expansion of the neurodegenerative therapies market.
CNS Clinical Trials conference you will examine the strategies offering
the greatest potential for success in CNS drug development, and understand the specifi c
challenges currently faced by developers in this market. In order to enhance productivity
in this fi eld, there has been an increased awareness of the need to align clinical and
preclinical research to facilitate rapid development of new CNS drug therapies. Medical
imaging is increasingly being used as a surrogate endpoint or biomarker of drug effi cacy
in all phases of CNS trials, enabling CNS developers to make more timely decisions.
Dates
Mar 15,2010 - Mar 16,2010 (Ended)
Venue
Address
236 City Road,
London,
United Kingdom
London,
United Kingdom
Prices *
2477 US Dollar
Organization
Bharat Book Bureau
Email
Categories
Health: Pharma
Important
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
Due to possible changes in conference details, we recommend that you check with the conference website, before making any traveling arrangements.
* Prices are for evaluation only. For accurate prices, please check with conference website.
from €108.03*
